Results 111 to 120 of about 88,675 (203)

SCN1A pathogenic variants do not have a distinctive blood‐derived DNA methylation signature

open access: yesEpilepsia, Volume 66, Issue 4, Page e66-e72, April 2025.
Abstract DNA methylation signatures (“episignatures”) can be used as biomarkers of genetic aberrations, clinical phenotypes, and environmental exposures in rare diseases. Episignatures are utilized in molecular diagnostics and can clarify variants of uncertain significance. A growing number of disease genes, including epilepsy genes, exhibit robust and
Christy W. LaFlamme   +14 more
wiley   +1 more source

B chromosome and its non-Mendelian inheritance in Atractylodes lancea. [PDF]

open access: yesPLoS One
Hara K   +7 more
europepmc   +1 more source

Phenotypic heterogeneity in familial epilepsies is influenced by polygenic risk for generalized and focal epilepsies

open access: yesEpilepsia, EarlyView.
Abstract Objective Although previous research shows that generalized and focal epilepsies have at least some distinct genetic influences, it remains uncertain why some families manifest both types of epilepsy. We tested two hypotheses: (1) families with both generalized and focal epilepsy carry separate risk alleles for both types; and (2) within mixed
Colin A. Ellis   +5 more
wiley   +1 more source

Clinical whole genome sequencing in pediatric epilepsy: Genetic and phenotypic spectrum of 733 individuals

open access: yesEpilepsia, EarlyView.
Abstract Objective A large proportion of pediatric epilepsies have an underlying genetic etiology. Limited studies have explored the efficacy of whole genome sequencing (WGS) in a clinical setting. Our academic–clinical center implemented clinical whole exome sequencing (WES) in 2014, then transitioned to WGS from 2015.
Olivia J. Henry   +10 more
wiley   +1 more source

Complex nutrient channel phenotypes despite Mendelian inheritance in a Plasmodium falciparum genetic cross. [PDF]

open access: yesPLoS Pathog, 2020
Gupta A   +9 more
europepmc   +1 more source

Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy

open access: yesEpilepsia, EarlyView.
Abstract De novo variants in KCNQ2 cause neonatal onset developmental and epileptic encephalopathy (KCNQ2‐DEE; Online Mendelian Inheritance in Man #613720), most often by loss‐of‐function in vitro effects. In this study, we describe a neonatal onset DEE proband carrying a recurrent de novo KCNQ2 variant (c.794C>T; p.A265V) affecting the pore domain of ...
Ingride Luzio Gaspar   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy